Traditional and emerging technologies for washing and volume reducing blood products

Millions of blood components including red blood cells, platelets, and granulocytes are transfused each year in the United States. The transfusion of these blood products may be associated with adverse clinical outcomes in some patients due to residual proteins and other contaminants that accumulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Madeleine, Lezzar, Dalia L, Vörös, Eszter, Shevkoplyas, Sergey S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322496/
https://www.ncbi.nlm.nih.gov/pubmed/30655711
http://dx.doi.org/10.2147/JBM.S166316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322496/
https://www.ncbi.nlm.nih.gov/pubmed/30655711
http://dx.doi.org/10.2147/JBM.S166316

Ejemplares similares